Previously, we reported that sustained degradation of BRD4 led to downregulation of CD44, MYC, and CXCR4 in acute myeloid leukemia (AML) stem cells and improved survival in a mouse model of AML [24]. This evidence concerns the gene CXCR4 and acute myeloid leukemia.